Health Industry

Latest KFF Health News Stories

Interactive: How Orphan Drugs Win The ‘Monopoly’ Game

KFF Health News Original

Check out all the drugs the FDA has approved to treat rare diseases. You can search by brand name, or by disease, and see familiar names that were first sold on the mass market or all the drugs that won FDA approval to treat more than one rare disease.

Merger May Revitalize California’s Flagging Effort To Pool Medical Records

KFF Health News Original

An Obama administration veteran will take the helm of Cal INDEX as it combines with the Inland Empire Health Information Exchange, creating a database covering nearly 17 million patients.

Federal Judge Denies Request To Delay EEOC Rules On Wellness Programs

KFF Health News Original

AARP had sought a preliminary injunction because it argued the new regulations – which allow employers to tie participation to 30 percent of the cost of individual health coverage – could be coercive.

Latest Hospital Injury Penalties Include Crackdown On Antibiotic-Resistant Germs

KFF Health News Original

Medicare reduced payments to 769 hospitals in the program, punishing facilities that have high rates of patient injuries, including infections, blood clots, falls and bed sores. This year, federal officials also added the prevalence of two dangerous bacteria.

Grilled About Deadly Superbug Outbreaks, Execs At Scope Maker Olympus Take Fifth

KFF Health News Original

Lawyers who deposed top company officials in a civil case say they declined to answer questions about their failure to warn American hospitals of infection risks. Industry giant Olympus also is the subject of a criminal probe.

After-Hours ER Care May Come With A Doctor’s Surcharge

KFF Health News Original

Patients sometimes find an additional charge, generally between $30 and $200, tacked onto their bill for visiting a hospital emergency room between 10 p.m. and 8 a.m.

Los ganadores y los perdedores del 21st Century Cures Act

KFF Health News Original

El 21st Century Cures Act que firmó el presidente Barack Obama el martes 13 de diciembre es un éxito legislativo para la industria farmacéutica. Qué podría pasar con los servicios de medicina preventiva.